About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Natco Pharma Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
524816
ISIN Demat
INE987B01026
Book Value
467.76
NSE Code
NATCOPHARM
Dividend Yield %
0.64
Market Cap
166831.89
P/E
11.12
EPS
83.75
Face Value
2
BSE
NSE
24-Mar-2026 10:42
BSE
NSE
NSE F & O
24-Mar-2026 10:34
BSE
NSE
NSE F & O
Last Price
927.05
Net Change
-0.7
% Change
-0.08%
Prev.Close
927.75
Open
959.95
High
959.95
Low
926.20
Volume
21573
Last Price
928.00
Net Change
0.45
% Change
0.05%
Prev.Close
927.55
Open
950.00
High
950.00
Low
928.00
Volume
154692
Value
19999249.65
Best Buy
927.90
Best Sell
929.20
Best Quantity
112
Sell Quantity
44
Today's Range
959.95
52-Week High
1059.60
52-Week Low
660.05
Value
143554176
Best Buy
928.05
Best Sell
928.65
Best Quantity
17
Sell Quantity
53
Today's Range
950.00
52-Week High
1059.00
52-Week Low
726.80
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
112
Price
927.90
Quantity
44
Price
929.20
Best Bid
Best Offer
Quantity
17
Price
928.05
Quantity
53
Price
928.65
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
26-Sep-24
30-Sep-24
Dividend
75 %
18-Feb-26
Company News
20-03-2026
NATCO Pharma informs abou...
06-03-2026
NATCO Pharma informs abo...
04-03-2026
Natco Pharma launches Pom...
04-03-2026
Natco Pharma rises on lau...
25-02-2026
Natco Pharma informs abou...
25-02-2026
Clarification sought fro...
24-02-2026
Clarification sought fro...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
